ProQR Therapeutics
PRQR
PRQR
46 hedge funds and large institutions have $111M invested in ProQR Therapeutics in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
43% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 14
97% less call options, than puts
Call options by funds: $2K | Put options by funds: $71K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
46
Holding in Top 10
–
Calls
$2K
Puts
$71K
Top Buyers
| 1 | +$3.36M | |
| 2 | +$1.9M | |
| 3 | +$1.19M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
+$1.07M |
| 5 |
Renaissance Technologies
New York
|
+$816K |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$5.32M | |
| 3 | -$1.93M | |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$193K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$189K |